Emerging Opportunities in Cancer Nucleic Acid Testing

February 2012 | 45 pages | ID: C7DFB2CEE2BEN
Venture Planning Group

Abstracts

The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing NAT technologies and products for cancer testing.

Contains 45 pages

Contents

1. OVERVIEW

2. MAJOR CANCER TYPES

Prostate
Lung
Colon and Rectum
Breast
Skin
Uterine
Leukemia
Oral

3. ONCOGENES

Abl/abl-bcr
AIB1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP17
Erb-B
HPC1
N-myc
P40
P51
P53
PIK3CA
PTI-1
Ras
Reg
Sis
Src

Tables

TABLES

Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests